November 19, 2025 · Form 4 insider transaction
Goin Kathleen bought 2,148 shares of Palvella Therapeutics at $9.08 per share, a transaction worth $19.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025.